US › Healthcare

Bionano Genomics Inc (BNGO)

US · Healthcare · Medical Instruments & Supplies

$1.12+0.45%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$6.7M
Revenue YoY
+3.6%
Net profit
$-8.3M
Profit YoY
-167.7%
EPS
$-0.75
EPS estimate
$-0.95
Net margin
-124.2%

EPS came in at -0.75 against a street estimate of -0.95 — a beat of 21.1%.

Key statistics

Market cap
$12.8M
Forward P/E
0.0
P/B
0.32
Book value
$3.32
EPS (TTM)
$-4.46
52-week high
$5.50
52-week low
$1.00
50-day MA
$1.16
200-day MA
$1.35
Beta
1.62

Analyst view

Analysts rate Bionano Genomics Inc a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $5.00.

Shareholding

Insiders
7.41%
Institutions
10.13%

Largest institutional holders

FundStake
GSA Capital Partners LLP3.19%
Geode Capital Management, LLC1.51%
Vanguard Group Inc0.74%
Carret & Company Inc0.63%
Vanguard Capital Management, LLC0.61%
Vanguard Fiduciary Trust Co0.47%
Renaissance Technologies Corp0.44%
Prudential Financial Inc0.25%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Bionano Genomics Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.